Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Shares Outstanding (2018 - 2025)

Neurogene's Shares Outstanding history spans 6 years, with the latest figure at $15.5 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 4.28% year-over-year to $15.5 million; the TTM value through Dec 2025 reached $15.5 million, up 4.28%, while the annual FY2025 figure was $15.5 million, 4.28% up from the prior year.
  • Shares Outstanding reached $15.5 million in Q4 2025 per NGNE's latest filing, up from $14.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $15.5 million in Q4 2025 to a low of $8.6 million in Q1 2023.
  • Average Shares Outstanding over 3 years is $13.0 million, with a median of $13.0 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding: skyrocketed 2821.44% in 2024, then increased 4.28% in 2025.
  • A 3-year view of Shares Outstanding shows it stood at $12.8 million in 2023, then grew by 15.84% to $14.9 million in 2024, then increased by 4.28% to $15.5 million in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Shares Outstanding are $15.5 million (Q4 2025), $14.8 million (Q3 2025), and $14.3 million (Q2 2025).